Compare DERM & GLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DERM | GLU |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.3M | 119.8M |
| IPO Year | 2021 | N/A |
| Metric | DERM | GLU |
|---|---|---|
| Price | $6.40 | $19.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 256.8K | 8.4K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.60% |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | ★ $61,858,000.00 | N/A |
| Revenue This Year | $39.72 | N/A |
| Revenue Next Year | $63.24 | N/A |
| P/E Ratio | ★ N/A | $31.46 |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $16.60 |
| 52 Week High | $9.56 | $21.69 |
| Indicator | DERM | GLU |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 45.43 |
| Support Level | $4.84 | $19.32 |
| Resistance Level | $6.71 | $20.17 |
| Average True Range (ATR) | 0.40 | 0.29 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 85.90 | 36.61 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.